Navigation Links
Reducing the side effects of treatment for prostate cancer
Date:8/27/2012

New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an anti-estrogen used to treat breast cancer, is also able to suppress gynecomastia and breast pain in men.

Prostate cancer is one of the most common cancers in men and early treatment is usually very successful. Androgen-suppression therapy is often used to slow down progression of advanced disease. However, unwanted side effects of anti-androgen treatment, such as breast enlargement, can stop men from seeking treatment for their cancer.

Testosterone can drive the growth of prostate cancer and anti-androgens are used to inhibit prostate cancer growth by preventing testosterone from binding to androgen receptors. But receptors in cells within the testes are also blocked and start to make more testosterone to compensate. Some of this extra testosterone is converted into estrogen which is responsible for development of breast tissue and other breast events. Anti-estrogens work by jamming the estrogen receptor, while aromatase inhibitors prevent the conversion of testosterone into estrogen.

A collaboration between the German Cochrane Center and University Clinic Erlangen combined data from four independent clinical trials each looking at the management of breast events (during treatment for prostate cancer) with tamoxifen.

A meta-analysis of all four trials showed that tamoxifen reduced the risk of both gynecomastia and breast pain at 3, 6, 9, and 12 months of treatment compared to men who received no treatment. Overall, treatment with tamoxifen was more successful in reducing breast symptoms than treatment with an aromatase inhibitor (anastrazole) or radiotherapy.

Although there is no long term data available, few of the men treated with tamoxifen, either as preventative or therapeutic treatment, stopped taking their medication during their year of treatment. There were also no significant adverse effects.

Dr Frank Kunath, who led this study explained, "Not all men will suffer gynecomastia during anti-androgen therapy. However, if men know that there is a successful option for reducing the breast symptoms associated with treatment for prostate cancer they may be more likely to see their doctor when symptoms of cancer first appear, and consequently reduce the number of unnecessary deaths."


'/>"/>
Contact: Hilary Glover
hilary.glover@biomedcentral.com
44-020-319-22370
BioMed Central
Source:Eurekalert

Related medicine news :

1. Researchers determine vitamin D blood level for reducing major medical risks in older adults
2. Reducing post-traumatic stress after ICU
3. Reducing off-label use of antipsychotic medications may save money
4. No Progress in Reducing U.S. Motorcycle Deaths: Report
5. Kitchen exhaust fans vary in effectiveness in reducing indoor air pollution
6. HPV Vaccine Reducing Infections, Even Among Unvaccinated: Study
7. A nursing program shows promise for reducing deaths from chronic illnesses
8. Reducing Ozone Limits Would Save Lives, Report States
9. Timing of antibiotics important in reducing infections after C-section
10. Young girls more likely to report side effects after HPV vaccine
11. Preteens More Likely to Report HPV Vaccine Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online plastic ... . The forum section was recently revamped and upgraded to allow even more interaction ... use across the country. , According to the senior editor of Cosmetic Town, “We ...
(Date:4/28/2016)... ... ... In many parts of the world, contamination from human waste is a ... in underdeveloped parts of Africa where clean sources of food and water are scarce. ... will examine this global health issue and consider how it compares to other major ...
(Date:4/28/2016)... , ... April 28, 2016 ... ... provider of enterprise Data Center Infrastructure Management solutions, announces today the availability ... feature enhancements in the area of capacity management and optimization, providing new ...
(Date:4/28/2016)... Texas (PRWEB) , ... April 28, 2016 , ... Amada ... opened its newest office in San Antonio – its San Antonio West location. Prior ... years in medical device sales. The grand opening of Amada San Antonio West will ...
(Date:4/28/2016)... ... April 28, 2016 , ... Anzu®, ... announced a new Residency Education & Collaboration Platform for hospitals and medical ... and a host of collaboration tools designed to improve patient outcomes through ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
(Date:4/27/2016)... , April 27, 2016 ... accelerator (MR-linac) platform will be the focal point of ... of the European Society for Radiotherapy & Oncology, taking ... MR-linac integrates a state-of-the-art radiotherapy system and a high-field ... to clearly see the patient,s anatomy in real time. ...
(Date:4/27/2016)... , April 27, 2016 Shire ... Jeff Poulton , Chief Financial Officer, will present at ... Boston, MA on Wednesday, May 04, 2016, ... webcast will be available on the Presentations and Webcasts section ... replay of the webcast will be available on this same ...
Breaking Medicine Technology: